Screening for carcinoma of the prostate: a GP based study
Authors:
- 1 July 1994
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 74 (1) , 64-71
Abstract
Objective To examine the feasibility and acceptability of screening for cancer of the prostate by digital rectal examination (DRE), prostate specific antigen (PSA) determination and subsequent transrectal ultrasound (TRUS) in selected patients in a single general practice in Hertfordshire. Subjects and methods A total of 568 of 856 men aged 55 to 70 accepted an invitation for a health check which included screening for prostate cancer. Of these, 80 individuals with either a raised PSA level or an abnormal DRE underwent TRUS. In 29 individuals biopsies were taken, 11 of which confirmed the presence of adenocarcinoma of the prostate giving an overall detected prevalence of 2%. Of the 11 tumours identified by screening, two were T 1 M o , four were T 2 M o , two were T 3 M o and three were T 3 M 1 . Results To assess the acceptability of the screening exercise a postal questionnaire was sent to all 568 participants: 83% replied and 69% reported no concern. Of the 67 individuals who had undergone TRUS, 69% reported discomfort. A total of 448 (95%) of respondents declared that they would be prepared to undergo the screening exercise again. Conclusion Screening for prostate cancer would seem to be technically feasible and generally acceptable. However, there is a considerable false positive rate in the PSA range 4 ng/ml to 10 ng/ml, particularly among men with clinical evidence of benign prostatic hyperplasia. To establish the true benefit of screening a large‐scale prospective controlled study will be necessary.Keywords
This publication has 29 references indexed in Scilit:
- Complications of Ultrasound‐guided Transperineal Prostate Biopsy A Prospective StudyBritish Journal of Urology, 1993
- Prostate cancer: to screen or not to screen?BMJ, 1993
- Prostate-specific antigen. Improving its ability to diagnose early prostate cancer1992
- High prevalence of benign prostatic hypertrophy in the communityThe Lancet, 1991
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- PATTERNS OF PROGRESSION IN PROSTATE CANCERThe Lancet, 1986
- Latent carcinoma of the prostateThe Journal of Pathology and Bacteriology, 1954